Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Saxagliptin (see drug summary box) is a glucose-lowering agent that belongs to the class of Dipeptidylpeptidase-4 (DDP-4) inhibitors used in the treatment of T2DM. Clinical efficacy of saxagliptin as single agent as well as in combination with other medications used for the treatment of T2DM has bee...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1517/14740338.2013.741584
データ提供：米国国立医学図書館（NLM）
Saxagliptin: A Review of Safety and Adverse Effects
This review delves into the safety and adverse effects of saxagliptin, a glucose-lowering agent used in the treatment of type 2 diabetes mellitus (T2DM). The authors provide a comprehensive overview of saxagliptin's clinical efficacy, highlighting its effectiveness as a single agent and in combination with other medications for T2DM management. They emphasize saxagliptin's generally safe and well-tolerated profile, noting a slight increase in the incidence of infections, such as nasopharyngitis. The authors discuss the implications of saxagliptin's use in patients with renal and hepatic impairment, as well as its interactions with other medications.
Navigating the Desert of Diabetes Management
This research, like a guide traversing the vast desert of diabetes management, provides valuable insights into the safety and efficacy of saxagliptin, a commonly prescribed medication for T2DM. The authors offer a comprehensive overview of saxagliptin's clinical profile, highlighting its effectiveness and generally favorable safety profile. This information is crucial for healthcare providers making treatment decisions for patients with T2DM, ensuring they are aware of potential risks and benefits.
A New Oasis in Diabetes Treatment
This review, like a refreshing oasis in the desert of diabetes treatment, offers a comprehensive understanding of saxagliptin's safety and efficacy. The authors provide valuable information regarding its potential benefits and risks, emphasizing its generally well-tolerated profile and specific considerations for patients with renal or hepatic impairment. This information empowers healthcare providers to make informed treatment decisions and optimize outcomes for patients with T2DM.
Dr.Camel's Conclusion
This review, like a caravan traversing the challenging landscape of diabetes management, provides valuable insights into the safety and efficacy of saxagliptin. The authors offer a comprehensive overview of saxagliptin's clinical profile, highlighting its effectiveness and generally favorable safety profile. This information is crucial for healthcare providers making treatment decisions for patients with T2DM, ensuring they are aware of potential risks and benefits.
Date :
- Date Completed 2013-05-29
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.